To explore how polymorphisms in the NOS3 gene may be of pathophysiological importance when considering the MetS risk in SCH and non-SCH subjects, we evaluated NOS3 polymorphisms for the associations with MetS biochemical traits in these groups (Table 4). This evidence concerns the gene NOS3 and spindle cell hemangioma.